July 8, 2020 / 12:45 PM / a month ago

BRIEF-Recce Pharmaceuticals Announces Recce® Compounds Selected By CSIRO/Doherty Institute In Priority 1 Candidate Group For SARS-COV-2 Antiviral Screening Program

July 8 (Reuters) - Recce Pharmaceuticals Ltd:

* RECCE PHARMACEUTICALS ANNOUNCES RECCE® COMPOUNDS SELECTED BY CSIRO/DOHERTY INSTITUTE IN PRIORITY 1 CANDIDATE GROUP FOR SARS-COV-2 ANTIVIRAL SCREENING PROGRAM Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below